Team:Hong Kong HKUST/hp/interview

From 2013.igem.org

(Difference between revisions)
Line 212: Line 212:
</div>
</div>
<div id="interview"><h3>Interview with Professor Albert Yu </h3>
<div id="interview"><h3>Interview with Professor Albert Yu </h3>
-
<div id="int-desc"><p id="int-desc-text" class="ya">Professor Albert Yu is the chairman of the Hong Kong Biotechnology Organization (HKBIO), and is also a professor of the Department of Neurobiology in Peking University, China. As an entrepreneur and a scientist, Prof. Yu gave us realistic insights to our project. Meeting Prof. Yu helped us to evaluate our project beyond the laboratory environment and to think about the possible future application as a biotechnology product. Towards the end of the interview, we also talked about the bio-ethics and bio-safety issues regarding synthetic biology. </p></div>
+
<div id="int-desc"><p id="int-desc-text" class="ya">Professor Albert Yu is the chairman of the Hong Kong Biotechnology Organization (HKBIO), and is also a professor of the Department of Neurobiology in Peking University, China. As an entrepreneur and a scientist, Prof. Yu gave us realistic insights to our project. Meeting Prof. Yu helped us to evaluate our project beyond the laboratory environment and to think about its application as a biotechnology product. Towards the end of the interview, we also talked about the bioethics and biosafety issues regarding synthetic biology. </p></div>
<div id="int-img"><img src="https://static.igem.org/mediawiki/2013/c/c1/Yu1.jpg" style="padding-left:10px;width:90%;padding-top:5px;"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview/yu"><img src="http://w1ggroup.com/devere/img/more_off.png" style="width:40%;height:40px;padding-top:10px;border-radius:10px;margin-bottom:10px;"></center></a></div></div>
<div id="int-img"><img src="https://static.igem.org/mediawiki/2013/c/c1/Yu1.jpg" style="padding-left:10px;width:90%;padding-top:5px;"><center><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview/yu"><img src="http://w1ggroup.com/devere/img/more_off.png" style="width:40%;height:40px;padding-top:10px;border-radius:10px;margin-bottom:10px;"></center></a></div></div>

Revision as of 18:08, 27 September 2013




Will It Work?

So, will our project be realistically applicable? With this in mind, we met with two well-known individuals in Hong Kong society. Professor Albert Yu and Professor Juliana Chan helped us to understand our project at a whole new level. As a scientist and an entrepreneur, Prof. Yu identified the issues that we need to consider if we want to see our project used as a biotechnology product. Prof. Chan, a medical doctor and an expert in diabetes, provided us with deeper insights on diabetes and the possible application of our project to fight diabetes and obesity.

Interview with Professor Albert Yu

Professor Albert Yu is the chairman of the Hong Kong Biotechnology Organization (HKBIO), and is also a professor of the Department of Neurobiology in Peking University, China. As an entrepreneur and a scientist, Prof. Yu gave us realistic insights to our project. Meeting Prof. Yu helped us to evaluate our project beyond the laboratory environment and to think about its application as a biotechnology product. Towards the end of the interview, we also talked about the bioethics and biosafety issues regarding synthetic biology.

Interview with Professor Juliana Chan

Professor Juliana Chan is a professor of medicine and therapeutics at the Chinese University of Hong Kong (CUHK). She is also director of the Hong Kong Institute of Diabetes and Obesity, CUHK, co-director of CUHK-Prince of Wales Hospital International Diabetes Federation Centre of Education (IDFCE), and chief executive officer of the Asia Diabetes Foundation. With extensive knowledge on diabetes, obesity and clinical practice, Prof. Chan brought to our attention practical aspects of developing treatments for medical purposes. Meeting Prof. Chan helped us to understand more about the biochemistry of diabetes. Also, by giving us information on current treatments for obesity and diabetes, she allowed us to consider our work in context. Towards the end of the interview, we also talked about the regulations for the development of new treatments in medical fields.

Aftermath

During both interviews, gene therapy and cell engineering were mentioned as technical methods to express our work as a treatment. After the interviews, we decided to do more detailed research on these two methods. Altogether, these interviews pointed at topics that we need to learn more about for the safe and effective application of our project.

Special Thanks!

Special thanks to Miss Willa Yau, Miss Elaine Li, and Kenneth Zhou for making the interviews possible.